DelSiTech Ltd.

Industry

  • Contract Research Organization-CRO
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Distributors
  • Medical Devices
    • Implantable Devices
See more in Biomedtracker

Latest on DelSiTech Ltd.

Scrip

Deal Watch: Merck KGaA Enhances Cell/Gene Therapy Capabilities With Mirus Takeout

 
• By Joseph Haas, Vibha Ravi, and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Merck KGaA Pays $600m For Transfection

Scrip

Deal Watch: Bristol Accesses Tech Platforms From SyntheX, Autolus

 
• By Joseph Haas and Mary Jo Laffler

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. BMS Calls On SyntheX, Autolus In Protei

Scrip

From Chengdu To The World: Anticancer Takes Novel Approach To Cancer Drug Development

 
• By Dexter Jie Yan

As China calls on domestic drug makers to develop medicaments that contain original innovation with first-in-class promise, Chengdu, China-based Anticancer Bioscience, Ltd. (ACB) is tapping into the

In Vivo

From Chengdu To The World: Anticancer Takes Novel Approach To Cancer Drug Development

 
• By Dexter Jie Yan

As China calls on domestic drug makers to develop medicaments that contain original innovation with first-in-class promise, Chengdu, China-based Anticancer Bioscience, Ltd. (ACB) is tapping into the